BlossomHill Therapeutics files for Nasdaq IPO under ticker BLSM

BlossomHill Therapeutics, Inc. has filed for an initial public offering of shares of common stock, according to a statement from the company.

The company has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol BLSM. The offering is contingent upon receiving approval for the listing. Prior to this offering, there has been no public market for the company's common stock.

The number of shares to be offered and the expected price range per share were not disclosed in the filing. Underwriters for the offering include J.P. Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital, and H.C. Wainwright & Co.

You May Also Be Interested In

• CoVolt Power files for proposed IPO
• Curvature Securities terminates ATM sales pact with Planet Green
• Winnebago Industries refinances credit facility, extends maturity to 2031